Free Trial

AdaptHealth (NASDAQ:AHCO) Trading Up 8.7% - What's Next?

AdaptHealth logo with Medical background

Key Points

  • AdaptHealth (NASDAQ: AHCO) shares surged 8.7%, reaching a last trading price of $9.91, despite a significant decline in trading volume compared to its average.
  • Recent analyst reports show Truist Financial and Royal Bank of Canada both lowered their price targets to $13.00, maintaining "buy" and "outperform" ratings, respectively.
  • Approximately 82.67% of AdaptHealth's stock is owned by institutional investors, highlighting strong interest from major investment entities.
  • Need Better Tools to Track AdaptHealth? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report)'s share price shot up 8.7% during mid-day trading on Tuesday . The company traded as high as $9.89 and last traded at $9.91. 796,754 shares traded hands during mid-day trading, a decline of 45% from the average session volume of 1,444,356 shares. The stock had previously closed at $9.11.

Wall Street Analyst Weigh In

AHCO has been the topic of several recent research reports. Truist Financial cut their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, May 12th. Royal Bank Of Canada dropped their target price on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Thursday, May 8th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $13.40.

Read Our Latest Report on AHCO

AdaptHealth Price Performance

The stock's 50 day moving average price is $9.05 and its two-hundred day moving average price is $9.33. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.29 and a quick ratio of 1.07. The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 0.84 and a beta of 1.58.

Institutional Trading of AdaptHealth

Institutional investors and hedge funds have recently modified their holdings of the company. GAMMA Investing LLC lifted its stake in shares of AdaptHealth by 175.2% in the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after buying an additional 4,758 shares during the last quarter. Oppenheimer Asset Management Inc. increased its position in AdaptHealth by 6.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company's stock worth $356,000 after acquiring an additional 2,081 shares during the period. New York State Teachers Retirement System increased its position in AdaptHealth by 3.3% during the first quarter. New York State Teachers Retirement System now owns 80,455 shares of the company's stock worth $872,000 after acquiring an additional 2,600 shares during the period. Janus Henderson Group PLC increased its position in AdaptHealth by 42.9% during the fourth quarter. Janus Henderson Group PLC now owns 38,298 shares of the company's stock worth $364,000 after acquiring an additional 11,500 shares during the period. Finally, Janney Montgomery Scott LLC bought a new position in AdaptHealth during the first quarter worth $854,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Company Profile

(Get Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AdaptHealth Right Now?

Before you consider AdaptHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.

While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines